TREM2 and Parkinson disease: Single-nucleotide polymorphisms, including the TREM2 R47H variant, increase the risk of dementia, including frontotemporal lobar degeneration, Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis46–49.